420 related articles for article (PubMed ID: 20037892)
1. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
[TBL] [Abstract][Full Text] [Related]
2. Protein oxidative stress and dyslipidemia in dialysis patients.
Marques de Mattos A; Marino LV; Ovidio PP; Jordão AA; Almeida CC; Chiarello PG
Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of plasma concentrations of homocysteine, IL-6, TNF-alpha, hs-CRP, and total antioxidant capacity in patients with end-stage renal failure.
Babaei M; Dashti N; Lamei N; Abdi K; Nazari F; Abbasian S; Gerayeshnejad S
Acta Med Iran; 2014; 52(12):893-8. PubMed ID: 25530051
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis.
Samouilidou EC; Grapsa EJ; Kakavas I; Lagouranis A; Agrogiannis B
Int Urol Nephrol; 2003; 35(3):393-7. PubMed ID: 15160547
[TBL] [Abstract][Full Text] [Related]
5. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
[TBL] [Abstract][Full Text] [Related]
7. Hemodialysis induces p66(shc) gene expression in nondiabetic humans: correlations with oxidative stress and systemic inflammation.
Zanetti M; Barazzoni R; Gortan Cappellari G; Burekovic I; Bosutti A; Stocca A; Bianco F; Ianche M; Panzetta G; Guarnieri G
J Ren Nutr; 2011 Sep; 21(5):401-9. PubMed ID: 21439852
[TBL] [Abstract][Full Text] [Related]
8. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Navarro JF; Mora C; Muros M; García-Idoate G
Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
[TBL] [Abstract][Full Text] [Related]
9. Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysis.
Guo CH; Wang CL; Chen PC; Yang TC
Perit Dial Int; 2011; 31(5):583-91. PubMed ID: 20592101
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress.
Takouli L; Hadjiyannakos D; Metaxaki P; Sideris V; Filiopoulos V; Anogiati A; Vlassopoulos D
Ren Fail; 2010 Jan; 32(3):287-93. PubMed ID: 20370442
[TBL] [Abstract][Full Text] [Related]
11. The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis.
Saddadi F; Alatab S; Pasha F; Ganji MR; Soleimanian T
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):66-72. PubMed ID: 24434384
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients.
Ohkuma T; Minagawa T; Takada N; Ohno M; Oda H; Ohashi H
Am J Kidney Dis; 2003 Aug; 42(2):355-61. PubMed ID: 12900819
[TBL] [Abstract][Full Text] [Related]
13. Elevated Plasma Cyclophillin A in Hemodialysis and Peritoneal Dialysis Patients: a Novel Link to Systemic Inflammation.
Jin K; Vaziri ND
Iran J Kidney Dis; 2017 Jan; 11(1):44-49. PubMed ID: 28174352
[TBL] [Abstract][Full Text] [Related]
14. [Effects of Salvia miltiorrhiza on oxidative stress and microinflammatory state in patients undergoing continuous hemodialysis].
Pu C; Yang YB; Sun QL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Sep; 26(9):791-4. PubMed ID: 17058827
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease.
Ahbap E; Sakaci T; Kara E; Sahutoglu T; Koc Y; Basturk T; Sevinc M; Akgol C; Kayalar AO; Ucar ZA; Bayraktar F; Unsal A
Clin Nephrol; 2016 Apr; 85(4):199-208. PubMed ID: 26521887
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
[TBL] [Abstract][Full Text] [Related]
18. Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.
Rangel-López A; Paniagua-Medina ME; Urbán-Reyes M; Cortes-Arredondo M; Alvarez-Aguilar C; López-Meza J; Ochoa-Zarzosa A; Lindholm B; García-López E; Paniagua JR
Mutagenesis; 2013 Mar; 28(2):219-25. PubMed ID: 23408844
[TBL] [Abstract][Full Text] [Related]
19. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
20. Cytokines, adipocytokines and inflammatory markers in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
Oncel M; Akbulut S; Toka Ozer T; Kiyici A; Keles M; Baltaci B; Turk S
Ren Fail; 2016 Aug; 38(7):1071-5. PubMed ID: 27267129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
